OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Musculoskeletal Disease is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Is there wastage in the research resources for ankylosing spondylitis? An analysis of clinical trial discontinuation and nonpublication outcome	77
Actigraphy-derived physical activity levels and circadian rhythm parameters in patients with psoriatic arthritis: relationship with disease activity, mood, age and BMI	42
An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis	37
Anti-sclerostin antibodies: a new frontier in fragility fractures treatment	35
Stakeholder perspectives on musculoskeletal pain assessment and management in the UK: a qualitative study	31
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study	27
The socioeconomic status of patients with ankylosing spondylitis and its association with the burden of the disease and permanent disability: a cross-sectional cluster analysis	27
Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis	26
Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients	25
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset	25
Cardio-rheumatology: integrated care and the opportunities for personalized medicine	19
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs	19
Reduced bone mineral density in patients with idiopathic inflammatory myopathies: a case-control study	19
From advanced imaging to molecular insights: the state of the art in omics for axial spondyloarthritis	17
Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension	16
Plain language summary: gout remission with pegloticase	14
Early knee OA definition–what do we know at this stage? An imaging perspective	14
The association between glucagon-like peptide-1 receptor agonist and rheumatoid arthritis: a population-based case–control study	14
Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes	14
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial	13
The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout	13
Effects of acupuncture versus placebo on clinical status and potential specific effects in Fibromyalgia: an umbrella review of 11 meta-analyses	13
T -score discordance between hip and lumbar spine: risk factors and clinical implications	13
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosi	12
Role of imaging for eligibility and safety of a-NGF clinical trials	12

Artificial intelligence in Kellgren–Lawrence grading of knee osteoarthritis: bridging radiographic tradition with algorithmic precision	12
Psoriatic arthritis management: a comparative analysis of PANLAR, EULAR, and GRAPPA treatment recommendations	11
Systemic lupus erythematosus is associated with increased risk of Parkinson’s disease	11
Implementation of clinical decision support tools for treatment selection in knee osteoarthritis: a scoping review	11
A transfer learning–based approach for automated bone fracture classification in X-ray imaging	10
Advanced imaging techniques in crystal arthritis	10
Development and evaluation of a multivariable prediction model for clinical improvement in an established cohort of Colombian rheumatoid arthritis patients	10
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care	10
Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis	10
A novel infrapatellar approach of ultrasound-guided intra-articular injection of the knee from both lateral and medial side: a case series	9
Gout therapy updated	9
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers	9
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multipl	9
Mechanisms hypothesized for pain-relieving effects of exercise in fibromyalgia: a scoping review	8
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy	7
Precision medicine using molecular-target drugs in psoriatic arthritis	7
The analysis of the pulmonary domain involvement in Sjögren’s disease	7
Precision medicine in axial spondyloarthritis: current opportunities and future perspectives	7
Ultrasound evaluation of finger joint cartilage damage progression in patients with rheumatoid arthritis	7
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)	6
Incidence of interstitial lung disease in seropositive rheumatoid arthritis patients receiving biologics, Janus kinase inhibitors, or methotrexate	6
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic	6
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthr	6
Latest insights in disease-modifying osteoarthritis drugs development	6
Associations of muscle mass, adipose tissue mass, and skeletal muscle radiodensity with disease activity in axial spondyloarthritis	6
Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy	6
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose	6
Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients	5
The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials	5
Effectiveness and safety of neridronate in chronic nonbacterial osteomyelitis: insight from the CAMELOT registry	5
Natural language processing to intercept rheumatoid and psoriatic arthritis from clinical notes in the Emergency Department	5
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab	5
The application of machine learning in early diagnosis of osteoarthritis: a narrative review	5
Impact of obesity on clinical outcomes and treatment continuation in rheumatoid arthritis patients receiving non-TNF-targeted therapies	5
Tofacitinib in early active axial spondyloarthritis: protocol of a randomized double-blind, placebo-controlled, multicenter phase IV study, FASTLANE	5